Does DABRAFENIB Cause Multiple sclerosis relapse? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Multiple sclerosis relapse have been filed in association with DABRAFENIB (Tafinlar). This represents 0.1% of all adverse event reports for DABRAFENIB.
9
Reports of Multiple sclerosis relapse with DABRAFENIB
0.1%
of all DABRAFENIB reports
0
Deaths
3
Hospitalizations
How Dangerous Is Multiple sclerosis relapse From DABRAFENIB?
Of the 9 reports, 3 (33.3%) required hospitalization.
Is Multiple sclerosis relapse Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DABRAFENIB. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does DABRAFENIB Cause?
Pyrexia (3,788)
Death (2,740)
Malignant neoplasm progression (1,667)
Fatigue (1,328)
Nausea (1,300)
Chills (1,235)
Rash (1,078)
Vomiting (907)
Diarrhoea (901)
Headache (697)
What Other Drugs Cause Multiple sclerosis relapse?
DIMETHYL (6,852)
FINGOLIMOD (6,728)
NATALIZUMAB (6,478)
INTERFERON BETA-1A (5,931)
TERIFLUNOMIDE (4,745)
GLATIRAMER (3,695)
DALFAMPRIDINE (3,322)
OCRELIZUMAB (2,326)
OFATUMUMAB (1,525)
INTERFERON BETA-1B (1,229)
Which DABRAFENIB Alternatives Have Lower Multiple sclerosis relapse Risk?
DABRAFENIB vs DABRAFENIB\TRAMETINIB
DABRAFENIB vs DACARBAZINE
DABRAFENIB vs DACLATASVIR
DABRAFENIB vs DACLIZUMAB
DABRAFENIB vs DACOMITINIB